Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Op den Winkel

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cancers|April 30, 2021
Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver CentersChristine Koch, Markus Göller, Eckart Schott, et al.
Plos One|October 17, 2012
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohortMark op den Winkel, Dorothea Nagel, Julia Sappl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 19, 2025
Diagnostic accuracy and Patient Derived Organoid (PDO) yield of 19G vs 22G Franseen needles for EUS-Guided biopsy in solid pancreatic lesions: A prospective comparative studySarah Klauss, Yonggan Xue, Ahmed Alnatsha, et al.
Digestive Diseases (Basel, Switzerland)|April 14, 2022
Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Max Seidensticker, et al.
Digestion|October 4, 2018
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Digestive Diseases (Basel, Switzerland)|June 10, 2021
A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation TherapyMark Op den Winkel, Dorothea Nagel, Manuel A de la Torre Aláez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinomaFrank T Kolligs, Jose I Bilbao, Tobias Jakobs, et al.
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
European Journal of Gastroenterology & Hepatology|October 28, 2017
Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE scoreMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cancers|April 30, 2021
Combination of Sorafenib and Transarterial Chemoembolization in Selected Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study at Three German Liver CentersChristine Koch, Markus Göller, Eckart Schott, et al.
Plos One|October 17, 2012
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohortMark op den Winkel, Dorothea Nagel, Julia Sappl, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 19, 2025
Diagnostic accuracy and Patient Derived Organoid (PDO) yield of 19G vs 22G Franseen needles for EUS-Guided biopsy in solid pancreatic lesions: A prospective comparative studySarah Klauss, Yonggan Xue, Ahmed Alnatsha, et al.
Digestive Diseases (Basel, Switzerland)|April 14, 2022
Development and External Validation of the Munich Sorafenib Evaluation Score for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Max Seidensticker, et al.
Digestion|October 4, 2018
The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular CarcinomaMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Digestive Diseases (Basel, Switzerland)|June 10, 2021
A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation TherapyMark Op den Winkel, Dorothea Nagel, Manuel A de la Torre Aláez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2014
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinomaFrank T Kolligs, Jose I Bilbao, Tobias Jakobs, et al.
International Journal of Cancer|January 27, 2017
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancerAndreas Herbst, Nikolay Vdovin, Sanja Gacesa, et al.
European Journal of Gastroenterology & Hepatology|October 28, 2017
Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE scoreMark Op den Winkel, Dorothea Nagel, Philip Op den Winkel, et al.
Pageof 3